News from nevro corp. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 18, 2023, 07:00 ET New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Aug 23, 2023, 07:00 ET Nevro Announces Participation in Upcoming Investor Conferences

Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

Aug 16, 2023, 07:00 ET New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy

Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today...

Aug 01, 2023, 16:03 ET Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Jul 13, 2023, 07:00 ET Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Jul 12, 2023, 07:00 ET Nevro to Present at the Canaccord Genuity 43rd Annual Growth Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Jun 27, 2023, 07:00 ET Nevro to Report Second Quarter 2023 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Jun 23, 2023, 07:00 ET Nevro Announces Painful Diabetic Neuropathy Clinical Data Presentations at the American Diabetes Association 83rd Scientific Sessions

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Jun 05, 2023, 16:05 ET Nevro Names New Chief Commercial Officer

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

May 22, 2023, 07:00 ET Nevro to Present at Jefferies Healthcare Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Apr 27, 2023, 16:05 ET Nevro Corp. Announces New Employment Inducement Grant under Section 303A.08 of the NYSE Listed Company Manual

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Apr 26, 2023, 16:05 ET Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Apr 24, 2023, 17:03 ET Nevro Announces Enrollment of First Patient in PDN Sensory Study

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Apr 24, 2023, 07:00 ET Nevro Announces Participation in Upcoming Investor Conferences

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Apr 19, 2023, 17:05 ET Nevro Names Kevin Thornal as New Chief Executive Officer and President

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Mar 29, 2023, 07:00 ET Nevro to Report First Quarter 2023 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Mar 07, 2023, 07:00 ET Nevro Announces U.S. Full Market Launch of Revolutionary HFX iQ™ Spinal Cord Stimulation System to Personalize Treatment of Chronic Pain

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Feb 23, 2023, 16:05 ET Nevro to Participate in Wells Fargo 2023 Medtech Innovation Spotlight Call Series

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Feb 16, 2023, 16:05 ET Nevro Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides First Quarter and Complete Full-Year 2023 Guidance

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Feb 01, 2023, 07:00 ET Nevro to Present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Jan 31, 2023, 16:05 ET Nevro Named to 2023 Bloomberg Gender-Equality Index for Second Consecutive Year

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Jan 19, 2023, 07:00 ET Nevro to Report Fourth Quarter and Full-Year 2022 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Jan 12, 2023, 07:00 ET Nevro to Highlight New Clinical Evidence at the 2023 North American Neuromodulation Society (NANS) 26th Annual Meeting

Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today...

Jan 09, 2023, 06:00 ET Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2022 Revenue and Provides Full-Year 2023 Revenue Guidance

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

Dec 19, 2022, 16:05 ET Nevro to Present at 41st Annual J.P. Morgan Healthcare Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain,...